Sleep Disorders in Patients With Multiple Sclerosis
Fatigue is a frequent and disabling symptom in patients with multiple sclerosis (MS). The pathophysiology of this sign is not fully understood. Some data suggest that the fatigue is associated with sleep disorders. The aim of this study is to determine the polysomnographic parameters in MS patients with fatigue in comparison to MS patients without fatigue...
Brief Summary
Official Title: “Study of Sleep Disorders and Fatigue in Patients With Multiple Sclerosis”
Fatigue is a frequent and disabling symptom in patients with multiple sclerosis (MS). The pathophysiology of this sign is not fully understood. Some data suggest that the fatigue is associated with sleep disorders. The aim of this study is to determine the polysomnographic parameters in MS patients with fatigue in comparison to MS patients without fatigue.
- Study Type: Observational
- Study Design: Observational Model: Case Control, Observational Model: Natural History, Time Perspective: Cross-Sectional, Time Perspective: Prospective
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients with multiple sclerosis
- Expanded Disability Status Scale score < or = 5
- Fatigue (Modified Fatigue Impact Scale > 45), with a disease duration > 3 months
Exclusion Criteria:
- Depression
- Cognitive disorders
- EDSS > 5
- Epilepsia
- Obesity
- Drug inducing sleep disorders
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 55 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Groupe Hospitalier Pitie-Salpetriere Other
Overall Clinical Trial Officials and Contacts
Bruno Stankoff, MD, PhD Principal Investigator CIC-Pitié-Salpêtrière
Overall Contact: Bruno Stankoff, MD, PhD 33-142161950 bruno.stankoff@psl.aphp.fr
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00137904
Study ID Number: RBM0242
ClinicalTrials.gov Identifier: NCT00137904
Health Authority: France: Ministry of Health
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00137904
